HOUSTON, April 15, 2021 /PRNewswire/ — Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology, today announced that the U.S. Food and Drug Administration (“FDA”) has accepted its special 510(k) application…